Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gene Therapy00:59

Gene Therapy

27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.

Haematologica·2026
Same author

Masked divergence in cancer mortality following COVID-19 disruption.

Cancer epidemiology·2026
Same author

Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

Current oncology (Toronto, Ont.)·2026
Same author

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Transplantation and cellular therapy·2026
Same author

Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

American journal of hematology·2026
Same author

From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.

Expert review of hematology·2026

相关实验视频

Updated: Jan 13, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K

从愿景到可行性:为细胞和基因治疗计划开发基础设施

Zahra Mahmoudjafari1, Joseph McGuirk1, Nausheen Ahmed1

  • 1The University of Kansas Cancer Center, Kansas City, KS.

Transplantation and cellular therapy
|January 9, 2026
PubMed
概括
此摘要是机器生成的。

实施细胞和基因疗法 (CGTs) 需要强大的机构基础设施. 该框架概述了安全,高效和可持续的CGT程序交付的关键领域,确保最佳的患者护理和访问.

更多相关视频

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

938
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.9K

相关实验视频

Last Updated: Jan 13, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

938
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.9K

科学领域:

  • 在瘤学瘤学.
  • 再生医学是一种再生医学.
  • 卫生系统管理管理卫生系统管理

背景情况:

  • 细胞和基因疗法 (CGTs) 在治疗复杂疾病方面取得了重大进展.
  • 实施CGT需要专门的基础设施,多学科协调和监管合规性.
  • 关于建立CGT计划的操作策略的文献有限.

研究的目的:

  • 提出一个实用的框架,用于建立机构基础设施,以支持CGT的交付.
  • 概述可行的策略,在临床,运营和财务方面实现CGT计划的运作.
  • 引导卫生系统建立安全,高效和可持续的CGT计划.

主要方法:

  • 描述性分析和综合早期采用者和认证标准的最佳实践.
  • 制定一个结构化的路线图,涵盖战略规划,治理和作战准备.
  • 没有统计分析的概念和操作框架.

主要成果:

  • 一个框架,有八个相互依存的领域,用于成功实施CGT计划.
  • 关键领域包括战略规划,运营准备,产品获取,药房整合,财务战略,技术整合,质量管理和宣传.
  • 该框架为减轻风险,提高患者安全并确保及时获得治疗提供了一个蓝图.

结论:

  • 综合集体劳动力车辆提供了变革的潜力,但需要有意识的基础设施开发.
  • 跨战略,运营和金融领域的多维准备对于高质量,公平的CGT交付至关重要.
  • 这一框架是为在快速发展的环境中实施CGT计划的中心提供指南.